DIA448.09+3.38 0.76%
SPX6,279.35+51.93 0.83%
IXIC20,601.10+207.97 1.02%

Centene, BrightView Holdings, ArriVent BioPharma And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Benzinga·07/02/2025 12:22:29
Listen to the news

U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Wednesday.

Shares of Centene Corporation (NYSE:CNC) fell sharply in today's pre-market trading after the health care company withdrew its guidance for 2025.

Centene withdrew its previous 2025 earnings guidance and all underlying guidance elements based on the company's preliminary interpretation of marketplace data from the independent actuarial firm Wakely.

Centene shares dipped 27.7% to $40.94 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

  • Molina Healthcare, Inc. (NYSE:MOH) tumbled 9% to $278.89 in pre-market trading.
  • BrightView Holdings, Inc. (NYSE:BV) dipped 8.8% to $15.37 in pre-market trading after the company lowered its FY25 revenue guidance from $2.75–$2.84 billion to $2.68–$2.73 billion.
  • Oscar Health, Inc. (NYSE:OSCR) shares fell 8.3% to $18.75 in pre-market trading after dipping 5% on Tuesday.
  • Mesoblast Limited (NASDAQ:MESO) fell 7.4% to $11.22 in pre-market trading. Mesoblast shares gained 11% on Tuesday after the company announced it is targeting an accelerated FDA approval for its heart failure drug Revascor.
  • ArriVent BioPharma, Inc. (NASDAQ:AVBP) fell 5.4% to $19.76 in pre-market trading as the company announced the pricing of $75 million public offering of common stock and pre-funded warrants.
  • DeFi Development Corp. (NASDAQ:DFDV) dipped 4.6% to $20.05 in pre-market trading after the company announced plans for a $100 million convertible notes offering.

Now Read This:

Photo via Shutterstock

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.